Thermo Fisher Scientific Inc. P/B Ratio
Data as of June 01, 2026
P/B Ratio
3.47
Stock Price
$492.51
Book Value/Share
$141.96
Sector
Healthcare
How It's Calculated
3.47 = $492.51 ÷ $141.96
What This Means
Thermo Fisher Scientific Inc.'s P/B ratio of 3.47 is above average, reflecting investor confidence in the company's ability to generate returns above its asset base.
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. (TMO) operates in the Healthcare sector, specifically in Diagnostics & Research. With a market capitalization of about $183.03B, it ranks as a large-cap stock — a major established company.
Shares recently traded near $492.51, within a 52-week range of $385.46 to $643.99 (-23.5% from the high, +27.8% from the low). Beta of 0.88 is broadly in line with typical market sensitivity.
Trailing profit margin is about 15.2%, signaling a solid profit margin for its industry.
Understanding This Metric
The price-to-book ratio compares market price to net asset value per share. For Thermo Fisher Scientific Inc., P/B is especially useful when earnings are volatile or temporarily depressed. In Healthcare, asset-heavy business models often anchor closer to book value, while asset-light models may trade far above book.
Sector Comparison
Among Healthcare names on our S&P 100 coverage, Thermo Fisher Scientific Inc.'s P/B ratio of 3.47 can be compared with peers such as LLY (31.65), JNJ (6.68), UNH (3.53). Sector context helps interpretation, but each company's growth profile and balance sheet differ — use multiple metrics before drawing conclusions. View all Healthcare stocks.
Key Takeaways
- TMO is grouped in the Healthcare sector for peer comparisons.
- Recent beta of 0.88 suggests lower-than-market price sensitivity.
- Trailing profit margin of 15.2% provides context for how much earnings support the headline multiple.
Related Tools & Guides
Explore calculators and guides connected to this metric, or view all metrics for TMO.
Other TMO Metrics
Frequently Asked Questions
What does TMO's price-to-book ratio indicate?
P/B compares share price to book value per share. Thermo Fisher Scientific Inc.'s P/B of 3.47 reflects how the market prices net assets — especially relevant for asset-heavy Healthcare business models.
Is 3.47 above or below book value?
A P/B above 1.0 (3.47) means the market values TMO above accounting book value — often due to brands, growth, or intangible assets.
How does P/B compare within Healthcare?
Peer P/B levels in Healthcare (e.g. LLY (31.65), AMGN (19.78), GILD (7.10)) provide context; asset-light vs asset-heavy models differ materially.
Calculate the p/b ratio for any stock with our free calculator.
Open P/B Ratio Calculator →